Replies to post #2934 on Cresco Labs Inc (CRLBF)

[FUNMAN]

Why ask your doctor when you do have to?

Nearly half of US breast cancer patients use cannabis medically, but don’t tell their doctor: study

https://mugglehead.com/nearly-half-of-us-breast-cancer-patients-use-cannabis-medically-but-dont-tell-their-doctor-study/

A majority of physicians aren’t equipped to talk about medical cannabis, and patients often look for information elsewhere

By Natalia Buendia Calvillo
Published
2 days ago

Almost half of US breast cancer patients use cannabis medically, but not thanks to their doctor

Patients seeking to use cannabis are more willing to go to the internet or other patients for information rather than their doctor.

Nearly half of American breast cancer patients are using cannabis to treat their symptoms, but not on their doctor’s advice.

That’s according to a study published in the journal American Cancer Society, where Pennsylvania-based researchers found that 42 per cent of breast cancer patients use cannabis to relieve pain, insomnia, anxiety, stress, nausea and vomiting.

“However, most patients do not discuss cannabis use with their physicians,” reads the study. “Instead, the internet and family or friends are the most common sources of cannabis information.”

Among those who consumed cannabis, 75 per cent reported it was extremely or very helpful at relieving symptoms, while only 39 per cent discussed it with their doctor.

Patients ranked websites and their peers as the most helpful sources of information, and physicians as the least. People who sought information on medical cannabis usually ended up feeling unsatisfied with it.

A national survey of 400 medical oncologists in 2018 found that 70 per cent felt unprepared to discuss cannabis use and to make recommendations to their patients.

Despite lack of clinical evidence supporting cannabis as a treatment option, nearly half of participants believed the plant could be used to treat cancer. Of the patients who consumed cannabis, 79 per cent reported use during therapies including radiation or surgery.

Patients reported using a wide range of different cannabis products. According to the study, most participants believed cannabis products are safe, but were unaware that the safety of many products is not tested.

Advocates for medical cannabis like Materia CEO Deepak Anand point out that patent safety is compromised in any situation where health professionals are unaware of pot use, as it can interact poorly with certain medications.

For the study, 612 U.S.-based breast cancer patients, and members of the non-profits Breastcancer.org and Healthline.com communities, filled anonymous surveys between Dec. 16, 2019 and Jan. 19, 2020.

Researchers aimed to characterize patterns of cannabis use among patients including reasons for use and timing of use, as well as the quality and location of their information.

Despite a lack of clinical research, the belief that cannabis cures cancer is not a new one. Since 2003 — when Rick Simpson Oil (RSO) was invented by its eponymous creator read early research on how cannabis could treat the disease — many people have followed his example, making high-THC oil to treat themselves or loved ones.

In Canada, a number of “RSO” branded cannabis products have appeared on the regulated market, which critics say have used the reputation of the unresearched cancer-killing oil as a marketing technique.

[FUNMAN]

Rep. Ed Perlmutter - Between a lack of basic banking services and issues accessing capital to facing a constant threat of violence to their business and employees, legitimate cannabis business owners face challenge after challenge.

??We need #SAFEBanking NOW

Between a lack of basic banking services and issues accessing capital to facing a constant threat of violence to their business and employees, legitimate cannabis business owners face challenge after challenge.

👏We need #SAFEBanking NOWhttps://t.co/Jwp59efxaB

— Ed Perlmutter (@RepPerlmutter) October 27, 2021

[FUNMAN]

Republicans may bail out dems legalization aspirations --->>> Republican-Led Bill To Legalize And Tax Marijuana Emerges As Alternative To Democratic Measures

Published 3 days ago on November 5, 2021

https://www.marijuanamoment.net/republican-led-bill-to-legalize-and-tax-marijuana-emerges-as-alternative-to-democratic-measures/

By Kyle Jaeger

A new Republican-led congressional marijuana legalization bill is imminent, Marijuana Moment has learned. The measure is being framed by advocates as a compromise between simple descheduling as proposed by other GOP lawmakers and wide-ranging comprehensive legislation that Democratic leaders are championing.

Marijuana Moment obtained text of the draft legislation, which is being led by Rep. Nancy Mace (R-SC). The measure, titled the States Reform Act, is currently being circulated among stakeholders for feedback and is therefore preliminary, but a final version is expected to be officially filed later this month.

This is yet another development in what’s proved to be an active year cannabis reform on Capitol Hill. But the GOP angle is notable, as many have raised doubts about the prospects of Congress passing the far-reaching, large-scale marijuana bills that Democrats are leading in the House and Senate. Getting Republican buy in could prove critical to getting something over the finish line, and the Mace measure seems aimed at appealing to the states’ rights and business interests of conservative colleagues on her side of the aisle while also incorporating some restorative justice and tax elements largely favored by progressives.

The freshman congresswoman, who was the sole GOP vote in favor of a cannabis research bill for veterans during a committee markup on Thursday, is aiming to federally deschedule marijuana and create a regulatory scheme—but still ensure that existing state markets are not unduly burdened or undermined by new rules.

Here’s a rundown of the details based on the draft legislation and summary documents obtained by Marijuana Moment:

-Cannabis would be federally descheduled and treated in a manner similar to alcohol.

-A 3.75 percent excise tax would be imposed on cannabis sales. Revenue would support grant programs for community reentry, law enforcement and Small Business Administration (SBA) aid for newly licensed businesses.

-The Treasury Department’s Alcohol and Tobacco Tax and Trade Bureau (TTB) would be the chief regulator for marijuana with respect to interstate commerce.

-The Food and Drug Administration (FDA) would be limited in its regulatory authority, with the intent being that it would have no more control over cannabis than it does for alcohol except when it comes to medical cannabis. The agency could prescribe serving sizes, certify designated state medical cannabis products and approve and regulate pharmaceuticals derived from marijuana, but could not ban the use of cannabis or its derivates in non-drug applications, like in designated state medical cannabis products, dietary supplements, foods, beverages, non-drug topicals or cosmetics.

-Raw cannabis would be considered an agricultural commodity regulated by the U.S. Department of Agriculture (USDA).

-The legislation would grandfather existing state-licensed cannabis operators into the federal scheme to ensure continued patient access and incentivize participation in the legal market.

-As federal agencies work to promulgate rules, there would be safe harbor provisions to protect patients and marijuana businesses acting in compliance with existing state laws.

-People with certain federal cannabis convictions that were non-violent would be eligible for expungements.

-To prevent youth use, there would be a mandatory 21 age limit for recreational cannabis, and the bill also prescribes certain restrictions on things like advertising.

-SBA would need to treat marijuana businesses the same as other regulated markets, like it does for alcohol companies, for example.

-The measure also stipulates that veterans can’t face discrimination in federal hiring due to cannabis use, and doctors with the U.S. Department of Veterans Affairs (VA) would be specifically authorized to issue recommendations for medical cannabis for veterans.

-Federal agencies could continue to drug test for marijuana.

-The Bureau of Labor Statistics (BLS) would be required to issue a report to Congress on the marijuana industry.

The draft bill is 116 pages, so these details represent just a portion of what’s comprised in the legislation. And again, the provisions are subject to change as the proposal is finalized ahead of its formal introduction in Congress.

—
Marijuana Moment is already tracking more than 1,200 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—

It’s also not clear what other GOP offices will be involved when the bill is officially rolled out. Marijuana Moment reached out to Mace’s office, but staff declined the opportunity to comment by time of publication.

The Republican-led effort sets the stage for some interesting debate. Advocates have already rallied behind measures such as the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act, which recently cleared the House Judiciary Committee, as well as a reform bill that’s being finalized on the Senate side, led by Majority Leader Chuck Schumer (D-NY), Senate Finance Committee Chairman Ron Wyden (D-OR) and Sen. Cory Booker (D-NJ).

It’s unlikely that the champions behind those measures would want to cede the issue to a Republican-led bill, even if it does contain components meant to appeal to Democrats and justice reform advocates.

But it’s possible the legislation will garner favor with industry stakeholders who are eager for a passable legalization proposal. Mace’s legislation takes specific steps to preserve the markets that have already been established in states while ensuring that they have the resources to expand under federal regulations.

Some Republicans have led, or joined their Democratic colleagues, on other marijuana bills, but they’ve generally been far more scaled back measures—simply protecting states that choose to legalize or descheduling cannabis without touching social equity issues or creating a federal tax on sales.

In any case, polling shows that the public is ready for an end to prohibition. Sixty-eight percent of U.S. adults said they back legalizing cannabis in a Gallup poll released this week—and that includes majorities of Democrats, Republicans and independents.

Yet, despite that support, President Joe Biden continues to oppose adult-use legalization. Instead, he’s supportive of more modest proposals to federally decriminalize cannabis, legalize the plant for medical use and let states set their own policies.

Whether he’d sign any Democratic- or Republican-led legalization bill is an open question.

While the president is personally against comprehensively ending prohibition, the Congressional Research Service released a report on Wednesday explaining steps he and his administration could take to repair the harms of cannabis criminalization.